Henry Mok

3.3k total citations
65 papers, 2.5k citations indexed

About

Henry Mok is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Henry Mok has authored 65 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Surgery, 25 papers in Pulmonary and Respiratory Medicine and 17 papers in Oncology. Recurrent topics in Henry Mok's work include Drug Transport and Resistance Mechanisms (11 papers), Gallbladder and Bile Duct Disorders (11 papers) and Advanced Radiotherapy Techniques (10 papers). Henry Mok is often cited by papers focused on Drug Transport and Resistance Mechanisms (11 papers), Gallbladder and Bile Duct Disorders (11 papers) and Advanced Radiotherapy Techniques (10 papers). Henry Mok collaborates with scholars based in United States, United Kingdom and Australia. Henry Mok's co-authors include Scott M. Grundy, R. H. Dowling, Loren A. Zech, Klaus von Bergmann, G. D. Bell, Robert S. Lees, Ann M. Lees, M. Berman, Mones Berman and Daniel Steinberg and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Henry Mok

61 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henry Mok United States 28 1.2k 563 562 491 450 65 2.5k
Eva Reihnér Sweden 25 2.0k 1.7× 818 1.5× 712 1.3× 247 0.5× 583 1.3× 52 3.0k
N. Moatti France 33 1.1k 0.9× 638 1.1× 201 0.4× 254 0.5× 581 1.3× 124 3.2k
Lynn J. Bennion United States 21 933 0.8× 507 0.9× 567 1.0× 637 1.3× 220 0.5× 26 2.2k
Eleni Bairaktari Greece 36 1.4k 1.1× 1.1k 2.0× 277 0.5× 352 0.7× 946 2.1× 146 3.9k
Nicola Carulli Italy 34 1.4k 1.1× 805 1.4× 840 1.5× 572 1.2× 618 1.4× 115 4.1k
S Ewerth Sweden 22 1.6k 1.4× 351 0.6× 735 1.3× 145 0.3× 481 1.1× 56 2.4k
Satoru Kakizaki Japan 32 771 0.6× 500 0.9× 709 1.3× 576 1.2× 666 1.5× 189 3.4k
Anne Dawnay United Kingdom 27 440 0.4× 559 1.0× 298 0.5× 342 0.7× 838 1.9× 91 3.4k
P. Haydn Pritchard Canada 38 1.9k 1.6× 1.2k 2.2× 402 0.7× 190 0.4× 1.5k 3.4× 111 4.3k
Stefano Ginanni Corradini Italy 30 1.2k 1.0× 289 0.5× 534 1.0× 368 0.7× 458 1.0× 136 3.2k

Countries citing papers authored by Henry Mok

Since Specialization
Citations

This map shows the geographic impact of Henry Mok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Mok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Mok more than expected).

Fields of papers citing papers by Henry Mok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry Mok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Mok. The network helps show where Henry Mok may publish in the future.

Co-authorship network of co-authors of Henry Mok

This figure shows the co-authorship network connecting the top 25 collaborators of Henry Mok. A scholar is included among the top collaborators of Henry Mok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry Mok. Henry Mok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hassanzadeh, Comron, Osama Mohamad, Teresa L. Bruno, et al.. (2025). Early outcomes following local salvage treatment with MRI-assisted low-dose rate brachytherapy (MARS) for MRI-visible postsurgical bed recurrences and focal intraprostatic recurrences. Brachytherapy. 24(2). 231–237. 1 indexed citations
3.
Hassanzadeh, Comron, Deborah A. Kuban, Roland L. Bassett, et al.. (2024). Hypofractionated, Dose-Escalated Radiation vs. Conventionally Fractionated Radiation for Localized Prostate Cancer: Long-Term Update of a Phase 3, Prospective, Randomized Controlled Trial. International Journal of Radiation Oncology*Biology*Physics. 120(2). S56–S56. 1 indexed citations
4.
Bathala, Tharakeswara, Steven J. Frank, Quynh‐Nhu Nguyen, et al.. (2023). Definitive local therapy for T4 prostate cancer associated with improved local control and survival. British Journal of Urology. 132(3). 307–313. 2 indexed citations
5.
Thames, Howard D., Jeremiah Sanders, Seungtaek Choi, et al.. (2023). Proton therapy for the management of localized prostate cancer: Long-term clinical outcomes at a comprehensive cancer center. Radiotherapy and Oncology. 188. 109854–109854. 4 indexed citations
6.
Tang, Chad, Jeremiah Sanders, Howard D. Thames, et al.. (2023). Outcomes after PD-103 versus I-125 for low dose rate prostate brachytherapy monotherapy: An international, multi-institutional study. Radiotherapy and Oncology. 183. 109599–109599. 5 indexed citations
7.
Sada, Yvonne H., Brandon G. Smaglo, Hop S. Tran Cao, et al.. (2019). National Trends in Multimodality Therapy for Locally Advanced Gastric Cancer. Journal of Surgical Research. 237. 41–49. 3 indexed citations
8.
Wald, Ori, Brandon G. Smaglo, Henry Mok, & Shawn S. Groth. (2017). Future directions in esophageal cancer therapy. Annals of Cardiothoracic Surgery. 6(2). 159–166. 18 indexed citations
9.
Asper, Joshua, Mark Bonnen, Henry Mok, et al.. (2017). Pre-treatment peer-review: enhancing value through increased efficiency and effectiveness of radiation oncology peer review. Journal of Radiation Oncology. 7(1). 97–102. 3 indexed citations
10.
Mok, Henry, Christopher H. Crane, Matthew B. Palmer, et al.. (2011). Intensity modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma. Radiation Oncology. 6(1). 63–63. 68 indexed citations
11.
Crane, Christopher H., Jaffer A. Ajani, Paul F. Mansfield, et al.. (2011). Intensity-Modulated Radiation Therapy With Concurrent Chemotherapy as Preoperative Treatment for Localized Gastric Adenocarcinoma. International Journal of Radiation Oncology*Biology*Physics. 83(2). 581–586. 36 indexed citations
12.
Debeb, Bisrat G., Wei Xu, Henry Mok, et al.. (2010). Differential Radiosensitizing Effect of Valproic Acid in Differentiation Versus Self-Renewal Promoting Culture Conditions. International Journal of Radiation Oncology*Biology*Physics. 76(3). 889–895. 37 indexed citations
13.
Kruyt, Frank A.E., et al.. (1999). Resistance to Mitomycin C Requires Direct Interaction between the Fanconi Anemia Proteins FANCA and FANCG in the Nucleus through an Arginine-rich Domain. Journal of Biological Chemistry. 274(48). 34212–34218. 49 indexed citations
14.
Mok, Henry, Klaus von Bergmann, John R. Crouse, & Scott M. Grundy. (1979). Biliary Lipid Metabolism in Obesity. Gastroenterology. 76(3). 556–567. 52 indexed citations
15.
Mok, Henry & Scott M. Grundy. (1978). Bile acid (BA) and cholesterol (CH) absorption during BA therapy in obese subjects undergoing weight reduction. Clinical research. 26(2). 3 indexed citations
16.
Mok, Henry, John R. Crouse, & Scott M. Grundy. (1977). Failure of chenodeoxycholic acid (CDCA) to reverse bile supersaturation in obese subjects on weight maintenance. Gastroenterology. 72. 2 indexed citations
17.
Grundy, Scott M. & Henry Mok. (1977). Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia.. PubMed. 89(2). 354–66. 63 indexed citations
18.
Grundy, Scott M., Henry Mok, & Klaus von Bergmann. (1976). Effects of obesity on turnover of very low density lipoprotein triglycerides (VLDL-TG). Circulation. 54. 2 indexed citations
19.
Mok, Henry, et al.. (1976). Effects of bile acid feeding on obese subjects undergoing weight reduction. Gastroenterology. 70. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eva Reihnér Breakdown of academic impact, for papers by N. Moatti Breakdown of academic impact, for papers by Lynn J. Bennion Breakdown of academic impact, for papers by Eleni Bairaktari Breakdown of academic impact, for papers by Nicola Carulli Breakdown of academic impact, for papers by S Ewerth Breakdown of academic impact, for papers by Satoru Kakizaki Breakdown of academic impact, for papers by Anne Dawnay Breakdown of academic impact, for papers by P. Haydn Pritchard Breakdown of academic impact, for papers by Stefano Ginanni Corradini
Rankless by CCL
2026